ScholarIQanswers from OpenAlex & ORCID
Fady T. Botros
ResearcherPublications, citations & collaboration network
Fady T. Botros is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Fady T. Botros have?
ScholarIQindexed works
Fady T. Botros has 64 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Fady T. Botros have?
ScholarIQcitation count
Fady T. Botros has 2,901 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Fady T. Botros?
ScholarIQh-index
Fady T. Botros has an h-index of 23 in OpenAlex.
What is the i10-index of Fady T. Botros?
ScholarIQi10-index
Fady T. Botros has an i10-index of 30 in OpenAlex.
What is the ORCID of Fady T. Botros?
ScholarIQorcid
The ORCID for Fady T. Botros is on the source record.
What is the OpenAlex record for Fady T. Botros?
ScholarIQopenalex
The OpenAlex for Fady T. Botros is on the source record.
What are the most-cited papers on Fady T. Botros?
ScholarIQmost cited works
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Katherine R Tuttle, Mark Lakshmanan, Brian Rayner, Robert S. Busch, Alan G. Zimmermann, D. Bradley Woodward, Fady T. Botros
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, Rafael Díaz, Mark Lakshmanan, Prem Pais, Jeffrey L. Probstfield, Fady T. Botros, Matthew C. Riddle, Lars Rydén, Denis Xavier, Charles Atisso, Leanne Dyal, Stephanie Hall, Rao Ps, G.C. Wong, Álvaro Avezum, Jan Basile, Namsik Chung, Ignacio Conget, William C. Cushman, Edward Franek, Nicolae Hâncu, M Hanefeld, Shaun Holt, Petr Janský, Mátyás Keltai, Fernando Laņas, Lawrence A. Leiter, Patricio López‐Jaramillo, Ernesto Muñoz, Valdis Pīrāgs, Nana Pogosova, Peter Raubenheimer, Jonathan E. Shaw, Wayne Huey‐Herng Sheu, Theodora Temelkova‐Kurktschiev, Mercedes Abella, Andrea Alebuena, Sandra Almagro, Eduardo Amoroso, Paula Anadon, Elizabeth Andreu, Guillermo Aristimuño, Maria Arzadun, María Antonietta Barbieri, Raúl Barcudi, Ines Bartolacci, Gabriel Bolobanich, Anselmo P. Bordonava, Miguel Bustamante Labarta, B. Bustos, Alberto Caccavo, Alejandra Camino, María del Rocío Cantero, Maria Carignano, Luis R Cartasegna, Marcela Cipullo, Víctor Commendatore, Victoria Conosciuto, Osvaldo Costamagna, Claudia A. Crespo, Jose Cuello, Carlos Alberto Cuneo, Sandra Cusimano, Sofia Dean, Claudio Fabián Dituro, Andrea Domínguez, Miguel Farah, Alberto Fernandez, Florencia Fernandez, Adriana Cristina Ferrari, Patricia Flammia, José Antonio Fuentealba, Karina Beatriz Gallardo, C. Perez Garcia, Ruben Garcia Duran, Marcelo Garrido, Rodolfo Gavícola, Claudio Gerbaudo, Graciela Gilli, Ana Paula Giotto, Pedro Godoy Bolzán, Oscar Gómez Vilamajó, Fernando Guerlloy, Cristian Guridi, Narcisa Gutierrez Garrido, Eduardo Hasbani, Sonia Hermida, Miguel Hominal, Adrian D. Hrabar, Adrián Ingaramo, Alejandra Izzicupo, Mario Krynski, Mariana Lagrutta, Paulina Virginia Lanchiotti, Maria Langhe, Veronica Leonard, Javier Llanos, Ricardo López Santi
Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program
Johan Jendle, George Grunberger, Thomas Blevins, Francesco Giorgino, Ryan T. Hietpas, Fady T. Botros
The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial
Hertzel C. Gerstein, Robert G. Hart, Helen M. Colhoun, Rafael Díaz, Mark Lakshmanan, Fady T. Botros, Jeffrey L. Probstfield, Matthew C. Riddle, Lars Rydén, Charles Atisso, Leanne Dyal, Stephanie Hall, Álvaro Avezum, Jan Basile, Ignacio Conget, William C. Cushman, Nicolae Hâncu, M Hanefeld, Petr Janský, Mátyás Keltai, Fernando Laņas, Lawrence A. Leiter, Patricio López‐Jaramillo, Ernesto Muñoz, Nana Pogosova, Peter Raubenheimer, Jonathan E. Shaw, Wayne Huey‐Herng Sheu, Theodora Temelkova‐Kurktschiev
Tadalafil for the Treatment of Pulmonary Arterial Hypertension
Ronald J. Oudiz, Bruce H. Brundage, Nazzareno Galiè, Hossein Ardeschir Ghofrani, Gérald Simonneau, Fady T. Botros, Melanie Chan, Anthony Beardsworth, Robyn J. Barst